海外の治験の状況「1」での検索結果
1852件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- The Effect of Intensive Home Based Speech Pathology Intervention on Speech, Swallowing and Quality of Life for Stroke Survivors.
- Dysarthria;dysphagia;oral/verbal dyspraxia
- Australia
- 2010-11-12
Not recruiting
- Effects of Switching From ATRIPLA^TM (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028)
- HIV-1 Infection;CNS Toxicity;HIV-1 Infection;CNS Toxicity
- Ireland, South Africa, United Kingdom
- 2016-01-08
Not Recruiting
- Ultrasound-guided transvaginal ovarian needle drilling
- Pregnancy and Childbirth Fertility-female Treatment of polycystic ovary syndrome;Pregnancy and Childbirth;Fertility-female;Treatment of polycystic ovary syndrome
- Egypt
- 2017-02-13
Not Recruiting
- Activity during television advertisement breaks to offset the adverse effects of prolonged sitting: The ‘Active Ads’ study
- impaired glucose tolerance ;obesity ;endothelial function ; insulin levels; impaired glucose tolerance obesity endothelial function insulin levels;Metabolic and Endocrine - Diabetes;Public Health - Health promotion/education
- Australia
- 2016-06-20
Not Recruiting
- Ovarian rejuvenation for menopausal or perimenopausal women using autologous platelet rich plasma (A-PRP) injection into the ovaries, for women seeking in vitro fertilisation (IVF) treatment, aiming to improve IVF outcomes.
- Premature ovarian failure;Poor ovarian response;Advanced maternal age; Premature ovarian failure br>Poor ovarian response Advanced maternal age;Reproductive Health and Childbirth - Fertility including in vitro fertilisation
- Australia
- 2019-08-29
Not recruiting
- An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
- Rheumatoid Arthritis;Rheumatoid Arthritis;Rheumatoid Arthritis;Rheumatoid Arthritis
- Argentina, Australia, Brazil, Chile, Colombia, Czech Republic, Czechia, Ecuador, Finland, France, Germany, Greece, Hungary, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, New Zealand, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Taiwan, Thailand, Ukraine, United Kingdom, United States
- 2013-01-08
Not Recruiting
- Efficacy and safety of fixed-dose combination Perindopril / Indapamide / Amlodipine versus Perindopril / Indapamide single pill in patients with uncontrolled essential hypertension after 1 month of treatment by Perindopril / Indapamide
- Uncontrolled essential hypertension MedDRA version: 15.0 Level: PT Classification code 10015488 Term: Essential hypertension System Organ Class: 10047065 - Vascular disorders ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Argentina, Brazil, Bulgaria, Czech Republic, Hungary, Poland, Romania, Russian Federation, Singapore, Slovakia, South Africa, Ukraine, Vietnam
- 2012-09-14
Not recruiting
- A pilot study of the effect of oral curcumin on lymphocyte count in patients with clinical stage 0/1 chronic lymphocytic leukemia.
- stage 0/1 chronic lymphocytic leukemia
- Australia
- 2015-05-15
Not recruiting
- A Phase I, Comparative Bioavailability Study of Dihydroergotamine Mesylate (DHE) Administered by I123 Precision Olfactory Delivery (PODTM) Device Nasal Spray, DHE for Injection (Intravenous), and Migranal® Nasal Spray in Healthy Male and Female adult Subjects
- Migraine headache
- Australia
- 2017-09-28
Not Recruiting
- Study Comparing Bevacizumab + Temsirolimus Vs Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects
- Advanced Renal Cell Carcinoma
- Argentina, Australia, Belgium, Brazil, Canada, Chile, Colombia, Croatia, Czech Republic, France, Germany, Hong Kong, Hungary, India, Italy, Malaysia, Mexico, Netherlands, Poland, Portugal, Republic of Korea, Russian Federation, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Taiwan, Ukraine, United Kingdom, United States of America
- 2009-08-06
Not recruiting
- Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects
- Renal Cell Carcinoma;Renal Cell Carcinoma;Renal Cell Carcinoma;Renal Cell Carcinoma
- Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Former Serbia and Montenegro, France, Germany, Hong Kong, Hungary, India, Italy, Korea, Republic of, Macau, Malaysia, Mexico, Netherlands, Poland, Portugal, Russian Federation, Serbia, Singapore, Slovakia, South Africa, Spain, Taiwan, Ukraine, United Kingdom, United States
- 2008-02-28
Not Recruiting
- The purpose of this study is to learn if BMS-512148 (dapagliflozin),after 12 wks,can improve (decrease) blood pressure in patients with Type 2 diabetes mellitus with uncontrolled hypertension who are on an Angiotensin-converting enzyme inhibitor (ACEI) or an Angiotensin Receptor Blocker (ARB).
- Type 2 Diabetes
- Australia, Colombia, Denmark, Finland, Germany, Hungary, Mexico, Poland, United Kingdom, United States of America
- 2011-09-02
Not recruiting
- Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
- Lymphoproliferative Disorder;Lymphoproliferative Disorder;Lymphoproliferative Disorder;Lymphoproliferative Disorder
- Australia, Canada, Netherlands, New Zealand, Puerto Rico, Switzerland, United States
- 2003-08-06
Not recruiting
- Open-label study to assess how the pharmacokinetics (i.e. the way the body absorbs, distributes and gets rid of a drug), safety, and tolerability of the drug siponimod are influenced by the presence of specific genetic characteristics (namely CYP2C9 genotypes).
- The medical condition pursued for siponimod is Secondary Progressive Multiple Sclerosis (SPMS). This study aims to characterize the PK profile of siponimod in healthy subjects with the CYP2C9 extensive and poor metabolizer phenotype.
- Australia, France, Jordan, Outside, United States of America
- 2013-05-15
Not recruiting
- Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
- Breast Adenocarcinoma;Estrogen Receptor Positive;HER2/Neu Negative;Progesterone Receptor Positive;Recurrent Breast Carcinoma;Stage IIIB Breast Cancer AJCC v7;Stage IIIC Breast Cancer AJCC v7;Stage IV Breast Cancer AJCC v6 and v7
- South Africa, United States
- 2014-04-14
Not Recruiting
- A Phase II Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of VS 6063 in Subjects with Malignant Pleural Mesothelioma
- MPM is a rare but aggressive tumor of the serosal surfaces (specifically the pleura and peritoneum) that is highly invasive and progresses rapidly. The main risk factor is exposure to carcinogenic silicate fibers found in asbestos, although genetic factors may also contribute. VS- 6063 is being studied as a maintenance treatment in subjects with MPM whose disease has not progressed (confirmed PR or SD) after adequate first-line treatment with pemetrexed plus platinum based chemotherapy. MedDRA version: 17.0 Level: PT Classification code 10059518 Term: Pleural mesothelioma malignant System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belgium, Canada, France, Italy, Japan, Netherlands, New Zealand, Norway, Poland, South Africa, Spain, Sweden, United Kingdom, United States
- 2013-04-29
Not recruiting
- APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis
- TTR-mediated Amyloidosis;Amyloidosis, Hereditary;Amyloid Neuropathies, Familial;Familial Amyloid Polyneuropathies;Amyloid Neuropathies;Amyloidosis, Hereditary, Transthyretin-Related
- Argentina, Australia, Brazil, Bulgaria, Canada, Cyprus, France, Germany, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, Portugal, Spain, Sweden, Taiwan, Turkey, United Kingdom, United States
- 2013-10-09
Not Recruiting
- Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic Countries
- Japanese Encephalitis (JE) MedDRA version: 14.1 Level: LLT Classification code 10023123 Term: Japanese encephalitis System Organ Class: 10021881 - Infections and infestations MedDRA version: 14.1 Level: LLT Classification code 10023120 Term: Japanese B viral encephalitis System Organ Class: 10021881 - Infections and infestations MedDRA version: 14.1 Level: LLT Classification code 10023122 Term: Japanese B virus encephalitis System Organ Class: 10021881 - Infections and infestations MedDRA version: 14.1 Level: LLT Classification code 10023119 Term: Japanese B encephalitis System Organ Class: 10021881 - Infections and infestations MedDRA version: 14.1 Level: PT Classification code 10014596 Term: Encephalitis Japanese B System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Australia, Denmark, Germany, Sweden, United States
- 2009-11-11
Not recruiting
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
- Breast Adenocarcinoma;Estrogen Receptor and/or Progesterone Receptor Positive;HER2/Neu Negative;Stage IA Breast Cancer AJCC v7;Stage IB Breast Cancer AJCC v7;Stage IIA Breast Cancer AJCC v6 and v7;Stage IIB Breast Cancer AJCC v6 and v7;Stage IIIB Breast Cancer AJCC v7
- Australia, Canada, Ireland, New Zealand, Peru, Puerto Rico, United Kingdom, United States
- 2006-03-29
Not Recruiting
- A Randomised, Double-blind, Active Treatment Study to Induce Clinical Response and/or Remission with GSK1605786A in Subjects with Moderately-to-Severely Active Crohn’s Disease
- Moderately-to-Severely Active Crohn’s Disease MedDRA version: 14.0 Level: PT Classification code 10011401 Term: Crohn's disease System Organ Class: 10017947 - Gastrointestinal disorders ;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Norway, Poland, Portugal, Russian Federation, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan, United Kingdom, United States
- 2011-12-14
